Abstract
In 1962 and 1963, Sanfilippo et al. described eight children with mental retardation and heparan sulfate mucopolysacchariduria and delineated the syndrome which now bears his name. Earlier in 1961, Harris reported a 6-year-old girl with hepatosplenomegaly, a normal skeletal survey, and excretion of large amounts of heparan sulfate in the urine. Sanfilippo syndrome is one of the most common mucopolysaccharidoses (MPS) (1/24,000–1/200,000).
References
Aldenhoven, M., Jones, S. A., Bonney, D., et al. (2015). Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: Results after implementation of international guidelines. Biology of Blood and Marrow Transplantation, 21, 1106–1109.
Andrade, F., Aldámiz-Echevarría, L., Llarena, M., et al. (2015). Sanfilippo syndrome: Overall review. Pediatrics International, 57, 331–338.
Baehner, F., Schmiedeskamp, C., Krummenauer, F., et al. (2005). Cumulative incidence rates of the mucopolysaccharidoses in Germany. Journal of Inherited Metabolic Disease, 28, 1011–1017.
Barone, R., Nigro, F., Triulzi, F., et al. (1999). Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome). Neuropediatrics, 30, 270–274.
Beesley, C. E., Young, E. P., Vellodi, A., et al. (1998). Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB). Journal of Medical Genetics, 35, 910–914.
Beesley, C. E., Young, E. P., Vellodi, A., et al. (2000). Mutational analysis of Sanfilippo syndrome type A (MPS IIIA): Identification of 13 novel mutations. Journal of Medical Genetics, 37, 704–707.
Beesley, C. E., Burke, D., Jackson, M., et al. (2003). Sanfilippo syndrome type D: Identification of the first mutation in the N-acetylglucosamine-6-sulphatase gene. Journal of Medical Genetics, 40, 192–194.
Beesley, C. E., Jackson, M., Young, E. P., et al. (2005). Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB). Journal of Inherited Metabolic Disease, 28, 759–767.
Blanch, L., Weber, B., Guo, X. H., et al. (1997). Molecular defects in Sanfilippo syndrome type A. Human Molecular Genetics, 6, 787–791.
Bodamer, O. A., Giugliani, R., & Wood, T. (2014). The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape. Molecular Genetics and Metabolism, 113, 34–41.
Buhrman, D., Thakkar, K., Poe, M., et al. (2014). Natural history of Sanfilippo syndrome type A. Journal of Inherited Metabolic Disease, 37, 431–437.
Bunge, S., Ince, H., Steglich, C., et al. (1997). Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A). Human Mutation, 10, 479–485.
Bunge, S., Knigge, A., Steglich, C., et al. (1999). Mucopolysaccharidosis type IIIB (Sanfilippo B): Identification of 18 novel alpha-N-acetylglucosaminidase gene mutations. Journal of Medical Genetics, 36, 28–31.
Chabas, A., Montfort, M., Martinez-Campos, M., et al. (2001). Mutation and haplotype analyses in 26 Spanish Sanfilippo syndrome type A patients: Possible single origin for 1091delC mutation. American Journal of Medical Genetics, 100, 223–228.
Cleary, M. A., & Wraith, J. E. (1993). Management of mucopolysaccharidosis type III. Archives of Disease in Childhood, 69, 403–406.
De Ruijter, J., Broere, L., Mulder, M. F., et al. (2014). Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease). Journal of Inherited Metabolic Disease, 37, 447–454.
Defendi, G. I., Varma, S. (2009). Mucopolysaccharidosis type III. eMedicine from WebMD. Updated May 14, 2009. Available at: http://emedicine.medscape.com/article/948540-overview
Dhallan, R., Au, W.-C., Mattagjasingh, S., et al. (2004). Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA, 291, 1114–1119.
Di Natale, P., Pannone, N., D’Argenio, G., et al. (1987). First-trimester prenatal diagnosis of Sanfilippo C disease. Prenatal Diagnosis, 7, 603–605.
Di Natale, P., Villani, G. R., Esposito, S., et al. (1999). Prenatal diagnosis of Sanfilippo type A syndrome in a family with S66W mutant allele. Prenatal Diagnosis, 19, 993–994.
Di Natale, P., Villani, G., Di Domenico, C., et al. (2003). Analysis of Sanfilippo A gene mutations in a large pedigree. Clinical Genetics, 63, 314–318.
He, W., Voznyi, Y. V., Huijmans, J. G., et al. (1994). Prenatal diagnosis of Sanfilippo disease type C using a simple fluorometric enzyme assay. Prenatal Diagnosis, 14, 17–22.
Hopwood, J. J. (2005). Prenatal diagnosis of Sanfilippo syndrome. Prenatal Diagnosis, 25, 148–150.
Jones, M. Z., Alroy, J., Rutledge, J. C., et al. (1997). Human mucopolysaccharidosis IIID: Clinical, biochemical, morphological and immunohistochemical characteristics. Journal of Neuropathology and Experimental Neurology, 56, 1158–1167.
Karpova, E. A., Voznyi, Y. V., Keulemans, J. L., et al. (1996). A fluorimetric enzyme assay for the diagnosis of Sanfilippo disease type A (MPS IIIA). Journal of Inherited Metabolic Disease, 19, 278–285.
Kleijer, W. J., Huijmans, J. G., Blom, W., et al. (1984). Prenatal diagnosis of Sanfilippo disease type B. Human Genetics, 66, 287–288.
Kleijer, W. J., Karpova, E. A., Geilen, G. C., et al. (1996). Prenatal diagnosis of Sanfilippo A syndrome: Experience in 35 pregnancies at risk and the use of a new fluorogenic substrate for the heparin sulphamidase assay. Prenatal Diagnosis, 16, 829–835.
Lee-Chen, G. J., Lin, S. P., Ko, M. H., et al. (2002a). Identification and characterization of mutations underlying Sanfilippo syndrome type A (mucopolysaccharidosis type IIIA). Clinical Genetics, 61, 192–197.
Lee-Chen, G. J., Lin, S. P., Lin, S. Z., et al. (2002b). Identification and characterisation of mutations underlying Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB). Journal of Medical Genetics, 39, E3.
Maire, I., Epelbaum, S., Piraud, M., et al. (1993). Second trimester prenatal diagnosis of Sanfilippo syndrome type C. Journal of Inherited Metabolic Disease, 16(3), 584–586.
Meikle, P. J., Hopwood, J. J., Clague, A. E., & Carey, W. F. (1999). Prevalence of lysosomal storage disorders. Journal of American the Medical Association, 281, 249–254.
Minelli, A., Danesino, C., Lo Curto, F., et al. (1988). First trimester prenatal diagnosis of Sanfilippo disease (MPSIII) type B. Prenatal Diagnosis, 8, 47–52.
Mossman, J., Young, E. P., Patrick, A. D., et al. (1983). Prenatal tests for Sanfilippo disease type B in four pregnancies. Prenatal Diagnosis, 3, 347–350.
Nidiffer, F. D., & Kelly, T. E. (1983). Developmental and degenerative patterns associated with cognitive, behavioural and motor difficulties in the Sanfilippo syndrome: An epidemiological study. Journal of Mental Deficiency Research, 27(Pt 3), 185–203.
Nowakowski, R. W., Thompson, J. N., & Taylor, K. B. (1989). Sanfilippo syndrome, type D: A spectrophotometric assay with prenatal diagnostic potential. Pediatric Research, 26, 462–466.
Nur, B. G., Nur, H., Mihci, E. (2016). Bone mineral density in patients with mucopolysaccharidosis type III. Journal of Bone and Mineral Metabolism. 2016 May 18 [Epub ahead of print].
Poorthuis, B. J., Wevers, R. A., Kleijer, W. J., et al. (1999). The frequency of lysosomal storage diseases in The Netherlands. Human Genetics, 105, 151–156.
Sivakumur, P., & Wraith, J. E. (1999). Bone marrow transplantation in mucopolysaccharidosis type IIIA: A comparison of an early treated patient with his untreated sibling. Journal of Inherited Metabolic Disease, 22, 849–850.
Thompson, J. N., Huffman, P., McConkie-Rosell, A., et al. (1993). Prenatal diagnosis of Sanfilippo syndrome type A by early amniocentesis. Biochemistry and Molecular Biology International, 29, 793–797.
Thornhill, A. R., & Snow, K. (2002). Molecular diagnostics in preimplantation genetic diagnosis. Journal of Molecular Diagnosis, 4, 11–29.
Toone, J. R., & Applegarth, D. A. (1988). Carrier detection in Sanfilippo A syndrome. Clinical Genetics, 33, 401–403.
Ucar, S. K., Ozbaran, B., Demiral, N., et al. (2010). Clinical overview of children with mucopolysaccharidosis type IIIA and effect of Risperidone treatment on children and their mothers psychological status. Brain & Development, 32, 156–161.
Valstar, M. J., Ruijter, G. J. G., van Diggelen, O. P., et al. (2008). Sanfilippo syndrome: A mini-review. Journal of Inherited Metabolic Disease, 31, 240–252.
Van de Kamp, J. J., Neirmeijer, M. F., Von Figura, K., et al. (1981). Genetic heterogeneity and clinical variability in the Sanfilippo syndrome (type A, B and C). Clinical Genetics, 20, 152–160.
Vance, J. M., Conneally, P. M., Wappner, R. S., et al. (1981). Carrier detection in Sanfilippo syndrome type B: Report of six families. Clinical Genetics, 20, 135–140.
Vellodi, A., Young, E., New, M., et al. (1992). Bone marrow transplantation for Sanfilippo disease type B. Journal of Inherited Metabolic Disease, 15, 911–918.
Yogalingam, G., & Hopwood, J. J. (2001). Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications. Human Mutation, 18, 264–281.
Zhao, H. G., Li, H. H., Bach, G., et al. (1996). The molecular basis of Sanfilippo syndrome type B. Proceedings of the National Academy of Sciences United States of America, 93, 6101–6105.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this entry
Cite this entry
Chen, H. (2017). Mucopolysaccharidosis 3. In: Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2401-1_163
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2401-1_163
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2400-4
Online ISBN: 978-1-4939-2401-1
eBook Packages: MedicineReference Module Medicine